Shanghai Begin Period Cash Flow from 2010 to 2025

688193 Stock   33.43  0.03  0.09%   
Shanghai Rendu's Begin Period Cash Flow is increasing over the years with slightly volatile fluctuation. Overall, Begin Period Cash Flow is expected to go to about 360.6 M this year. Begin Period Cash Flow is the amount of cash Shanghai Rendu Biotechnology has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. View All Fundamentals
 
Begin Period Cash Flow  
First Reported
2010-12-31
Previous Quarter
343.4 M
Current Value
360.6 M
Quarterly Volatility
129.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Shanghai Rendu financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Shanghai Rendu's main balance sheet or income statement drivers, such as Net Interest Income of 10 M, Interest Income of 10.5 M or Selling General Administrative of 109.5 M, as well as many indicators such as . Shanghai financial statements analysis is a perfect complement when working with Shanghai Rendu Valuation or Volatility modules.
  
This module can also supplement various Shanghai Rendu Technical models . Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Currently Active Assets on Macroaxis

Other Information on Investing in Shanghai Stock

Shanghai Rendu financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Rendu security.